Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
67
+2 vs. Q1 2024
Portfolio value
$3.35B
−$130.3M (−3.7%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Deep Track Capital, LP in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
AMGNAmgen IncStock575,000$179.7M5.4%+25,000+4.5%AddedHistory
ARGXArgenx SESPONSORED ADR400,000$172.0M5.1%+100,000+33.3%AddedHistory
AXSMAxsome Therapeutics, Inc.COM1,852,784$149.1M4.5%+548,063+42.0%AddedHistory
DYNDyne Therapeutics, Inc.COM4,000,000$141.2M4.2%−555,383−12.2%ReducedHistory
SWTXSpringWorks Therapeutics, Inc.COM3,700,000$139.4M4.2%+220,147+6.3%AddedHistory
INSMINSMED IncCOM PAR $.012,000,000$134.0M4.0%−2,783,679−58.2%ReducedHistory
GHGuardant Health, Inc.COM4,500,000$130.0M3.9%−1,500,000−25.0%ReducedHistory
DVAXDynavax Technologies CorpCOM NEW10,900,000$122.4M3.7%+1,758,340+19.2%AddedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM500,000$121.5M3.6%−332,310−39.9%ReducedHistory
NTLAIntellia Therapeutics, Inc.COM4,800,000$107.4M3.2%+589,216+14.0%AddedHistory
ITCIIntra-Cellular Therapies, Inc.COM1,537,922$105.3M3.1%+37,922+2.5%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM2,500,000$95.9M2.9%+1,500,000+150.0%AddedHistory
IONSIonis Pharmaceuticals IncCOM2,000,000$95.3M2.8%+626,525+45.6%AddedHistory
OCULOcular Therapeutix, IncCOM12,721,460$87.0M2.6%00.0%UnchangedHistory
FDMT4D Molecular Therapeutics, Inc.COM4,061,401$85.2M2.5%+1,026,948+33.8%AddedHistory
ALKSAlkermes plc.SHS3,500,000$84.3M2.5%00.0%UnchangedHistory
NRIXNurix Therapeutics, Inc.COM3,991,500$83.3M2.5%+993,670+33.1%AddedHistory
IMVTImmunovant, Inc.COM2,883,736$76.1M2.3%+2,390,384+484.5%AddedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS3,490,506$70.6M2.1%00.0%UnchangedHistory
PLRXPliant Therapeutics, Inc.COM5,972,257$64.2M1.9%+222,257+3.9%AddedHistory
TVTXTravere Therapeutics, Inc.COM7,370,000$60.6M1.8%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS4,000,000$57.8M1.7%+812,585+25.5%AddedHistory
ABVXAbivax S.A.SPONSORED ADS4,179,763$55.3M1.7%−117,675−2.7%ReducedHistory
GERNGeron CorpCOM13,000,000$55.1M1.6%−17,505,929−57.4%ReducedHistory
AUTLAutolus Therapeutics plcSPON ADS15,272,172$53.1M1.6%00.0%UnchangedHistory
TGTXTG Therapeutics, Inc.COM2,870,131$51.1M1.5%+2,870,131NewHistory
VRDNViridian Therapeutics, Inc.COM3,923,849$51.0M1.5%+467,796+13.5%AddedHistory
KYMRKymera Therapeutics, Inc.COM1,500,000$44.8M1.3%+237,754+18.8%AddedHistory
DFTXDefinium Therapeutics, Inc.Stock6,103,817$44.0M1.3%−562,850−8.4%ReducedHistory
OLMAOlema Pharmaceuticals, Inc.COM4,000,000$43.3M1.3%+774,581+24.0%AddedHistory
TERNTerns Pharmaceuticals, Inc.COM6,100,000$41.5M1.2%00.0%UnchangedHistory
SYRESpyre Therapeutics, Inc.COM NEW1,756,667$41.3M1.2%+543,247+44.8%AddedHistory
APGEApogee Therapeutics, Inc.COM1,000,000$39.4M1.2%−1,323,456−57.0%ReducedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS950,000$37.3M1.1%+909,863+2,266.9%AddedHistory
ANIPAni Pharmaceuticals IncCOM466,089$29.7M0.9%−355,912−43.3%ReducedHistory
EDITEditas Medicine, Inc.COM6,000,000$28.0M0.8%+472,710+8.6%AddedHistory
CLYMClimb Bio, Inc.COM3,904,785$27.8M0.8%+3,904,785NewHistory
HLVXHilleVax, Inc.COM1,832,652$26.5M0.8%−739,808−28.8%ReducedHistory
KRROKorro Bio, Inc.COM770,645$26.1M0.8%+770,645NewHistory
SLNSilence Therapeutics plcADS1,359,745$25.8M0.8%−284,136−17.3%ReducedHistory
NKTRNektar TherapeuticsCOM17,875,498$22.2M0.7%−524,502−2.9%ReducedHistory
ENGNenGene Therapeutics Inc.COM2,250,000$21.2M0.6%00.0%UnchangedHistory
ALECAlector, Inc.COM4,631,998$21.0M0.6%+862,612+22.9%AddedHistory
ETNB89bio, Inc.COM2,294,011$18.4M0.5%+2,294,011NewHistory
FATEFate Therapeutics IncCOM5,572,607$18.3M0.5%00.0%UnchangedHistory
INOInovio Pharmaceuticals, Inc.COM SHS2,066,720$16.7M0.5%+2,066,720NewHistory
PRAXPraxis Precision Medicines, Inc.COM NEW389,546$16.1M0.5%+389,546NewHistory
Cybin Ord23256X100COM58,139,535$15.8M0.5%00.0%Unchanged–
CNTXContext Therapeutics Inc.COM7,419,355$14.9M0.4%+7,419,355NewHistory
PYXSPyxis Oncology, Inc.COMMON STOCK4,184,100$13.8M0.4%00.0%UnchangedHistory
IVVDInvivyd, Inc.COM10,953,937$12.0M0.4%00.0%UnchangedHistory
ZURAZura Bio LtdCLASS A ORD SHS3,283,783$11.5M0.3%+760,783+30.2%AddedHistory
KURAKura Oncology, Inc.COM384,756$7.92M0.2%+384,756NewHistory
CYTKCytokinetics IncCOM NEW132,495$7.18M0.2%+132,495NewHistory
RGLSRegulus Therapeutics Inc.COM3,262,564$5.82M0.2%−4,002−0.1%ReducedHistory
ANROAlto Neuroscience, Inc.COM SHS511,686$5.47M0.2%−88,314−14.7%ReducedHistory
AGENAgenus IncCOM NEW313,359$5.25M0.2%−1,271,518−80.2%ReducedConverted for a 1-for-20 splitHistory
ALLKAllakos Inc.COM5,000,000$5.00M0.1%00.0%UnchangedHistory
SYRSSyros Pharmaceuticals, Inc.COM NEW828,485$4.27M0.1%00.0%UnchangedHistory
RLMDRelmada Therapeutics, Inc.COM1,234,773$3.70M0.1%−5,261−0.4%ReducedHistory
EWTXEdgewise Therapeutics, Inc.COM186,386$3.36M0.1%+186,386NewHistory
SRRKScholar Rock Holding CorpCOM372,559$3.10M0.1%−307,441−45.2%ReducedHistory
RPTXRepare Therapeutics Inc.COM904,261$2.98M0.1%−1,780,083−66.3%ReducedHistory
COGTCogent Biosciences, Inc.COM308,235$2.60M0.1%−7,765−2.5%ReducedHistory
VIGLVigil Neuroscience, Inc.COM597,215$2.39M0.1%−997,716−62.6%ReducedHistory
ALGSAligos Therapeutics, Inc.COM6,102,770$2.14M0.1%00.0%UnchangedHistory
MGXMetagenomi Therapeutics, Inc.COM466,232$1.90M0.1%00.0%UnchangedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q2 2024
SecurityClassPutsCalls
NMRANeumora Therapeutics, Inc.COM–$1.77M

Sold out since Q1 2024 (8)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
TRMLTourmaline Bio, Inc.COM1,595,400$36.5M1.1%History
PACBPacific Biosciences of California, Inc.COM7,000,000$26.3M0.8%History
NUVLNuvalent, Inc.COM274,512$20.6M0.6%History
NMRANeumora Therapeutics, Inc.COM1,000,000$13.8M0.4%History
ANABAnaptysbio, IncCOM529,452$11.9M0.3%History
RAREUltragenyx Pharmaceutical Inc.COM167,784$7.83M0.2%History
MRSNMersana Therapeutics, Inc.COM579,674$2.60M0.1%History
PRMEPrime Medicine, Inc.COM303,716$2.13M0.1%History